|
miRNA Biomarker for Detecting Increased Risk of Brain Metastasis in NSCLC Patients
Through a collaboration of TGen, Honor Health, and Arizona State University, a method for classifying a non-small cell lung cancer (NSCLC) patient as having an increased risk of brain metastasis by detecting a microRNA (miRNA) biomarker in a sample was developed. Through the ability to stratify NSCLC patients with a high risk for brain metastasis,...
Published: 6/24/2024
|
Inventor(s): Glen Weiss, Seungchan Kim, Sara Nasser
Keywords(s):
Category(s): Diagnostics
|
